<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">27760526</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>N-terminal pro-brain natriuretic peptide levels associated with severe hand, foot and mouth disease.</ArticleTitle><Pagination><StartPage>585</StartPage><MedlinePgn>585</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">585</ELocationID><Abstract><AbstractText Label="BACKGROUND">Severe hand, foot, and mouth disease (HFMD) is sometimes associated with serious complications such as acute heart failure that can cause substantial child mortality. N-terminal pro-brain natriuretic peptide (NT-proBNP) is a sensitive and specific biomarker of congestive heart failure. The aim of this study was to use plasma NT-proBNP levels to establish the severity of childhood HFMD.</AbstractText><AbstractText Label="METHODS">A retrospective study was performed in 128 Chinese patients with severe HFMD and 88 patients with mild HFMD treated between January 2014 and October 2015. Univariate and multiple logistic regression analyses were used to analyze the risk factors for severe HFMD. NT-proBNP levels were analyzed in 128 severe HFMD patients, and the predictive value of NT-proBNP was assessed by receiver operating characteristic analyses.</AbstractText><AbstractText Label="RESULTS">Multivariate analysis controlling for several potential confounders showed that enterovirus 71 infection [odds ratio (OR) 19.944, 95&#xa0;% confidence interval (CI) 6.492-61.271], peripheral WBC count (OR 3.428, 95&#xa0;% CI 1.186-9.914), fasting glucose (OR 19.428, 95&#xa0;% CI 2.236-168.784), procalcitonin (OR 9.084, 95&#xa0;% CI 3.462-23.837, and NT-proBNP (&gt;125&#xa0;pg/mL) (OR 16.649, 95&#xa0;% CI 4.731-58.585) were each associated with the severity of HFMD. The 45 dead severe patients had higher pre-procedural levels of NT-proBNP than the 83 cured severe patients (12776&#x2009;&#xb1;&#x2009;13115 versus 1435&#x2009;&#xb1;&#x2009;4201&#xa0;pg/mL, P&#x2009;&lt;&#x2009;0.001). An NT-proBNP cutoff value of 982&#xa0;pg/mL predicted mortality with 87&#xa0;% sensitivity and 86&#xa0;% specificity.</AbstractText><AbstractText Label="CONCLUSION">Plasma NT-pro-BNP level appears to be a useful biological marker for predicting the severity and mortality of HFMD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Hui-Ling</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Xi'an Children's Hospital, Xi'an, 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu-Feng</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Xi'an Children's Hospital, Xi'an, 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ya-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Xi'an Children's Hospital, Xi'an, 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Xi'an Children's Hospital, Xi'an, 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Xi'an Children's Hospital, Xi'an, 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiao-Yan</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Xi'an Children's Hospital, Xi'an, 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>Shuang-Suo</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China. dang212@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C109794">pro-brain natriuretic peptide (1-76)</NameOfSubstance></Chemical><Chemical><RegistryNumber>114471-18-0</RegistryNumber><NameOfSubstance UI="D020097">Natriuretic Peptide, Brain</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020097" MajorTopicYN="N">Natriuretic Peptide, Brain</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Disease severity</Keyword><Keyword MajorTopicYN="N">Hand, foot, and mouth disease</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">N-terminal pro-brain natriuretic peptide</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>10</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27760526</ArticleId><ArticleId IdType="pmc">PMC5069980</ArticleId><ArticleId IdType="doi">10.1186/s12879-016-1929-9</ArticleId><ArticleId IdType="pii">10.1186/s12879-016-1929-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Choi CS, Choi YJ, Choi UY, Han JW, Jeong DC, Kim HH, et al. Clinical manifestations of CNS infections caused by enterovirus type 71. Korean J Pediatr. 2011;54:11&#x2013;6. doi: 10.3345/kjp.2011.54.1.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2011.54.1.11</ArticleId><ArticleId IdType="pmc">PMC3040360</ArticleId><ArticleId IdType="pubmed">21359055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Lin TY, Chiang PS, Li WC, Luo ST, Tsao KC, et al. An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr Infect Dis J. 2010;29:1030&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">20543760</ArticleId></ArticleIdList></Reference><Reference><Citation>Shekhar K, Lye MS, Norlijah O, Ong F, Looi LM, Khuzaiah R, et al. Deaths in children during an outbreak of hand, foot and mouth disease in Peninsular Malaysia--clinical and pathological characteristics. Med J Malaysia. 2005;60:297&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">16379183</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushner D, Caldwell BD. Hand-foot-and-mouth disease. J Am Podiatr Med Assoc. 1996;86:257&#x2013;259. doi: 10.7547/87507315-86-6-257.</Citation><ArticleIdList><ArticleId IdType="doi">10.7547/87507315-86-6-257</ArticleId><ArticleId IdType="pubmed">8699347</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Liu CF, Yan L, Li JJ, Wang LJ, Qi Y, et al. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J. 2012;9:8. doi: 10.1186/1743-422X-9-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-8</ArticleId><ArticleId IdType="pmc">PMC3268717</ArticleId><ArticleId IdType="pubmed">22230340</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341:936&#x2013;42. doi: 10.1056/NEJM199909233411302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis. 2000;31:678&#x2013;683. doi: 10.1086/314032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X, Huang X, Zhu S, Chen H, Yu Q, Wang H, et al. The persistent circulation of enterovirus 71 in People&#x2019;s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One. 2011;6:e25662. doi: 10.1371/journal.pone.0025662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025662</ArticleId><ArticleId IdType="pmc">PMC3181342</ArticleId><ArticleId IdType="pubmed">21980521</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Tan X, Cui A, Mao N, Xu S, Zhu Z, et al. Complete genome analysis of the C4 subgenotype strains of enterovirus 71: predominant recombination C4 viruses persistently circulating in China for 14&#xa0;years. PLoS One. 2013;8:e56341. doi: 10.1371/journal.pone.0056341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056341</ArticleId><ArticleId IdType="pmc">PMC3575343</ArticleId><ArticleId IdType="pubmed">23441179</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Luo Z, Wang J, Xu Z, Chen H, Fan D, et al. Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009. PLoS One. 2013;8:e56318. doi: 10.1371/journal.pone.0056318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056318</ArticleId><ArticleId IdType="pmc">PMC3572022</ArticleId><ArticleId IdType="pubmed">23418551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung YA, Hung CT, Liu YC, Shih SR. Update on the development of enterovirus 71 vaccines. Expert Opin Biol Ther. 2014;14:1455&#x2013;64. doi: 10.1517/14712598.2014.935330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.2014.935330</ArticleId><ArticleId IdType="pubmed">24989170</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BY, Wateska AR, Bailey RR, Tai JH, Bacon KM, Smith KJ. Forecasting the economic value of an Enterovirus 71 (EV71) vaccine. Vaccine. 2010;28:7731&#x2013;6. doi: 10.1016/j.vaccine.2010.09.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.09.065</ArticleId><ArticleId IdType="pmc">PMC2989421</ArticleId><ArticleId IdType="pubmed">20923711</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Tseng FC, Wang JR, Chi CY, Chong P, Su IJ. Challenges to licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis. 2012;6:e1737. doi: 10.1371/journal.pntd.0001737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001737</ArticleId><ArticleId IdType="pmc">PMC3429393</ArticleId><ArticleId IdType="pubmed">22953003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1998;332:78&#x2013;81. doi: 10.1038/332078a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/332078a0</ArticleId><ArticleId IdType="pubmed">2964562</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson NC, Struthers AD. Brain natriuretic peptide. J Hypertens. 1994;12:329&#x2013;36. doi: 10.1097/00004872-199404000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004872-199404000-00001</ArticleId><ArticleId IdType="pubmed">8064155</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan SL, Lin SJ, Fu YC, Lin MC, Chan SC, Hwang B. Plasma B-type natriuretic peptide study in children with severe enterovirus 71 infection: a pilot study. Int J Infect Dis. 2013;17:e1166&#x2013;71. doi: 10.1016/j.ijid.2013.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2013.06.012</ArticleId><ArticleId IdType="pubmed">23932576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402&#x2013;12. doi: 10.1172/JCI115146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI115146</ArticleId><ArticleId IdType="pmc">PMC295184</ArticleId><ArticleId IdType="pubmed">1849149</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean AS, Huang SJ. Brain not processing: is finding a role for BNP in sepsis like fitting a square peg into a round hole? Crit Care. 2014;18:161. doi: 10.1186/cc13960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13960</ArticleId><ArticleId IdType="pmc">PMC4095610</ArticleId><ArticleId IdType="pubmed">25042534</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan SL, Fu YC, Hwang B, Lin SJ. B-type natriuretic peptide in children with atrial or ventricular septal defect: a cardiac catheterization study. Biomarkers. 2012;17:166&#x2013;71. doi: 10.3109/1354750X.2011.649494.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1354750X.2011.649494</ArticleId><ArticleId IdType="pubmed">22235950</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161&#x2013;7. doi: 10.1056/NEJMoa020233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa020233</ArticleId><ArticleId IdType="pubmed">12124404</ArticleId></ArticleIdList></Reference><Reference><Citation>Olalla J, Crespo E, De la Torre J, Sempere M, Del Arco A, Prada JL, et al. Factors related to NT-proBNP levels in HIV patients aged over 40&#xa0;years. AIDS Res Ther. 2015;12:17. doi: 10.1186/s12981-015-0058-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12981-015-0058-7</ArticleId><ArticleId IdType="pmc">PMC4426165</ArticleId><ArticleId IdType="pubmed">25960760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao HY, et al. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis. BMJ Open. 2015;5:e006703. doi: 10.1136/bmjopen-2014-006703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-006703</ArticleId><ArticleId IdType="pmc">PMC4401842</ArticleId><ArticleId IdType="pubmed">25872939</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajaniemi SM, Hautala N, Sironen T, Vainio O, Vapalahti O, Vaheri A, et al. Plasma B-type natriuretic peptide (BNP) in acute Puumala hantavirus infection. Ann Med. 2014;46:38&#x2013;43. doi: 10.3109/07853890.2013.862960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890.2013.862960</ArticleId><ArticleId IdType="pubmed">24393073</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C, Yibing C, Guo Y, Jin Z, Cui Y, Gu X. Risk factors of severe hand, foot and mouth disease complicated with cardiopulmonary collapse. Infect Dis (Lond) 2015;47:453&#x2013;7. doi: 10.3109/23744235.2015.1015051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/23744235.2015.1015051</ArticleId><ArticleId IdType="pubmed">25712793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health of the People&#x2019;s Republic of China. Hand, Foot and Mouth Disease Clinic Guide (2010 edition). Available: http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohyzs/s3586/201004/46884.htm(in Chinese). Accessed 19 Jan 2012.</Citation></Reference><Reference><Citation>Takemura G, Fujiwara H, Takatsu Y, Fujiwara T, Nakao K. Venticular expression of atrial and brain natriuretic peptides in patients with myocarditis. Int J Cardiol. 1995;52:213&#x2013;22. doi: 10.1016/0167-5273(95)02468-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-5273(95)02468-9</ArticleId><ArticleId IdType="pubmed">8789180</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro AL, Reis AM, Teixeira MM, Rocha MO. Brain natriuretic peptide in Chagas&#x2019; disease: further insights. Lancet. 2003;362:333. doi: 10.1016/S0140-6736(03)13990-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13990-6</ArticleId><ArticleId IdType="pubmed">12892979</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron MB, Holcomb PH, Dawson CA, Rickaby DA, Clough AV, Linehan JH. Edema developmerit and recovery in neurogenie pulmonary edema. J Appl Physiol. 1994;77:1155&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pubmed">7836117</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, Quak SH. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis. 2010;14:e1076&#x2013;81. doi: 10.1016/j.ijid.2010.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.07.006</ArticleId><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>